|
|
| |
|
July 5, 2007 |
| |
|
Welcome to ACAAI eNews — a bi-weekly
aggregated
news service
from the American College of Allergy, Asthma & Immunology. To be
removed from this distribution list, please see instructions at
bottom. |
| |
 |
Top
Stories |
|
|
|
 |
Distance Learning |
|
|
|
 |
Drugs and Devices |
|
|
|
 |
Association
News |
| |
|
 |
Fellows-in-Training |
| |
|
 |
Periodicals |
|
|
 |
Calendar |
| |
|
 |
Archive |
|
|
|
|
 |
FIT Archive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Of readers
responding who currently hold a lifetime certificate, 83 percent
do not plan to participate in MOC. |
|
|
|
|
|
|
|
|
|
|
Distance Learning |
ACAAI
Podcast/Vodcast Library
Link
2006 ACAAI Annual Meeting CD-ROM
Plenary Sessions
Literature Review
International Food Allergy Symposium
Link
|
Periodicals |
•
Annals of
Allergy, Asthma and Immunology
Current issue
• AllergyWatch
Current issue
|
Calendar |
|
JULY
Intermountain West Allergy Association
Pending ACAAI Joint Sponsorship
July 19-23, Spokane, Wash.
Tel: 509-924-9722
E-mail
2007 International Congress on Respiratory Viruses
The Macrae Group
July 20-22, Colorado Springs, Colo.
Tel: 212-988-7732
E-mail
Link
25th Annual Aspen Allergy Conference
Pending ACAAI Joint Sponsorship
July 24-28, Aspen, Colo.
Conference Coordinator: Jill Hibbeln
Tel: 720-384-5917
E-mail
Link
AUGUST
Tennessee Society of Allergy, Asthma & Immunology
Pending ACAAI Joint Sponsorship
Aug. 18-20, Knoxville, Tenn.
Tel: 865-342-7057
E-mail
SEPTEMBER
The Long Island Allergy & Asthma Society
Pending ACAAI Joint
Sponsorship
Sept. 7-9, Manhasset
Tel: 516-365-6077
E-mail
New York Allergy and Asthma
Society
Pending ACAAI Joint Sponsorship
Sept. 19, New York, N.Y.
Tel: 212-288-2278
E-mail
OCTOBER
Meadowbrook Med Ed Research Foundation at NUMC
Pending ACAAI Joint Sponsorship
Oct. 4, East Meadow, N.Y.
Tel: 718-631-9440
E-mail
1st International Congress on Exacerbations of Airway
Disease (ICEAD)
The Macrae Group
Oct. 4-7, San Juan, Puerto Rico
Tel: (+1) 212.988.7732
E-mail
Link
II Immunotherapy Course: The Insights of Effective
Vaccine for Allergy
Mexican College of Pediatric Allergy & Immunology
Recognized by ACAAI
Oct. 12-13, Mexico City
Tel: +52-55-9000-2008
E-mail
Link
Oregon Society of Allergy, Asthma & Immunology
Pending ACAAI Joint Sponsorship
Oct. 13-14, Mt. Vernon, Va.
Tel: 360-708-9555
E-mail
New York Allergy & Asthma Society
Pending ACAAI Joint Sponsorship
Oct. 26, Brooklyn, N.Y.
Tel: 718-377-0011
E-mail
ONGOING
World Allergy Organization Society Meetings
ACAAI CME Website
Contact: Mary Campbell
Tel: 847-427-1200
E-mail
|
Sponsored
By |
 |
|
|
|
|
|
|
|
|
| |
Top
Stories |
| |
|
Supplemental selenium
doesn’t improve asthma
Supplementing with selenium doesn’t appear to
have clinical benefit in adults with asthma, according to a
study in Thorax, even though selenium levels tend to
be low among that population. Researchers at Imperial
College London tested 197 adults from London with asthma,
randomly assigning subjects to receive for 24 weeks either a
yeast and selenium (100 micrograms daily) preparation or
yeast-only placebo. Subjects receiving the selenium
preparation had a 48-percent increase in blood levels of
selenium during the trial. However, while some indicators of
asthma severity improved more in the selenium group than in
the placebo group, the difference was not statistically
significant.
AMA votes to lobby for laws allowing
anaphylaxis treatment
drugs at school
Delegates at the American Medical Association
recently voted at its annual policy meeting to lobby for
laws allowing severely allergic children to bring lifesaving
drugs to school. The new policy refers to drugs including
prescription epinephrine and other injectable medicines that
treat severe allergic reactions. The policy also urges
schools to develop preparedness plans for handling severe
allergic reactions and ensuring that all affected children
have an individual emergency care plan.
Five percent in U.S. report food
allergies
More than 5 percent of U.S. adults may have food
allergies, according to a study in the Journal of Allergy
and Clinical Immunology. Researchers at the Food and
Drug Administration used data from a 2001 national survey.
About half of those with food allergies reported being
allergic to at least one of the eight most common food
allergens: milk and other dairy foods; fish; eggs;
crustaceans, such as lobster and shrimp; tree nuts, such as
walnuts; peanuts; soy; and wheat. Among those who read food
labels, 40 percent reported “serious” or “very serious”
difficulty trying to protect themselves. However, since the
survey was administered, new legislation that went into
effect in 2006 now requires food makers to list the eight
most common food allergens in plain English.
|
| |
A message from ACAAI President Dr. Daniel Ein
I recently attended an event with a number of twentysomethings, all of whom happened to be working on Wall Street, all trading different types of securities. (Apparently, being a trader is the new hot thing these days. The traders are the darlings of The Street, probably because they make the most money for their firms.) One of these young people, who happens to have gotten his position because his father is a billionaire hedge fund operator, was making fun of one of his buddies because his friend entertained the idea of going to medical school when his mother had been diagnosed with recurrent breast cancer. The young “Master of the Universe” teased his friend about what he called “the demented notion” of becoming a doctor.
Now, I have to admit, in the spirit of full disclosure, that my two sons have both spent time at major Wall Street firms. They have since graduated to what I consider more creative business pursuits. But I was horrified by the callousness and crass materialism I heard. The teasing was not meant as an observation of how difficult it is to be a doctor these days, but a statement that someone has to be intellectually defective to consider giving up a life of making big money for a life of helping others.
This got me thinking about my residents and students, the wonderful young people who are still full of idealism about and enthusiasm for what they are doing, who are eager to learn and anxious to be of service. Many of them remind me of myself and my classmates years ago. What I heard also caused me to reflect on my own 35 years of practice. The moments that have given me the greatest satisfaction mostly have to do with patients who return to tell us that they are so much better and so grateful for the change we have made in their lives.
Many of us feel so assaulted by the daily hassles: the endless regulations, the fighting with insurers and administrators, the loss of autonomy and respect, the relegation to “interchangeable units of production.” We forget what is really important about our professional lives, and that is that we are privileged to be able to practice medicine and have a positive impact on the lives of others.
Atul Gawande, a Harvard surgeon and a talented writer whose work mostly appears in The New Yorker, has written a new book, Better, about how physicians continually try to improve their performance for the sake of their patients, despite numerous internal and external obstacles. He concludes with five principles that he believes should guide us in our quest to be better physicians. One is “don’t complain,” even though we all have horror stories about the difficulty of practicing medicine these days. He points out that complaining doesn’t change anything, but does get us down. I would add that we should, in the words of the old song, “accentuate the positive and decentuate the negative.”
When we are really honest with ourselves, have we not had richer, more fulfilled lives by easing the suffering of others instead of having made money for someone else, by selling a bond at 21 instead of 20 7/8?
|
|
|
Drugs
and Devices |
|
|
|
Symbicort now available in
U.S.
AstraZeneca recently announced that Symbicort
(combination budesonide/formoterol) pressurized metered dose
inhaler is now available in the United States for the
long-term maintenance treatment of asthma in patients 12
years of age and older. Symbicort is approved for patients
whose disease is not adequately controlled on another
asthma-controller medication or whose disease severity
clearly warrants initiation of treatment with two
maintenance therapies. It is available in two dose
strengths, 80/4.5 and 160/4.5 µg of budesonide and
formoterol, respectively.
 |
|
|
Association
News |
| |
CMS begins
voluntary Physician Quality Reporting Initiative (PQRI)
On July 1, the Centers for Medicare and Medicaid Services
(CMS) began the voluntary Physician Quality Reporting
Initiative (PQRI). To assist physicians and other eligible
professionals who may elect to participate, the American
Medical Association in collaboration with CMS, Mathematica
Policy Research, Inc., and the National Committee for
Quality Assurance, has developed participation tools.
The tools are designed to: aid in the selection of measures
by physicians and other eligible professionals wishing to
participate in the program; link to background information
on the quality measures, including both the rationale and
evidence base for each measure; and aid in the data
collection required to report clinical performance data.
59 of the 74 measures in the PQRI were developed by the
AMA-convened Physician Consortium for Performance
Improvement®, in collaboration with the National Committee
for Quality Assurance (NCQA) and/or a medical specialty
society. ACAAI was one of the first participants in the
Consortium and continues to play an active role.
For each of the measures in the program, the tools are now
available
online. CMS also posted technical corrections to
some of the program's measure specifications. Additional
information can be found on the CMS website:
•
2007 Physician Quality Reporting Initiative (PQRI) Measure
Specifications [PDF, 812KB] - Updated 06/19/07
• June 18, 2007
Technical Corrections Release Notes, Version 1.1
[PDF, 19KB]
• General CMS PQRI
Web site for additional information
Opa! Screening program goes to Greece,
reaches ethnic
groups stateside
Joining Argentina, British Columbia, Ecuador, Panama, and
Puerto Rico, Greece became the newest international site in
the Nationwide Asthma Screening Program and extended the
reach of the public service campaign.
ACAAI member Dr. John Moissidis was a first-time coordinator
this year, and worked with the American Community Schools in
Athens to conduct a three-day event.
“We partnered with the heads of schools, teachers, and
nurses to coordinate the screening,” said Dr. Moissidis.
“Thanks to our combined efforts, we were able to screen kids
from elementary, middle, and high schools to increase
awareness of the importance of diagnosing asthma early. It
was a very successful project.”
The screening in Greece was one of more than 250 offered in
2007 by 208 ACAAI member allergists. The program is
supported by AstraZeneca to help diagnosed asthmatics and
people with breathing problems determine if they might have
asthma and make sure the disease is under control.
Other efforts to expand on the success of the campaign were
led by coordinators Drs. Ricardo Tan, Luz Fonacier and
Sheldon Spector, who introduced the screening program to the
International Association of Filipino Allergists and
Immunologists. The 200-member group is coordinating efforts
to screen the underserved Filipino-American communities.
Overall results of the 2007 program will be reported in
upcoming issues of ACAAI News and the program’s
Special Report newsletter.

ACAAI member Dr. John Moissidis screens a student in
Athens,Greece
Annals is gaining impact
The Impact Factor of Annals of Allergy, Asthma &
Immunology is on the rise, announced Editor-in-Chief Dr.
Gailen D. Marshall.
Annals Impact Factor
2006 – 2.254
2005 – 1.987
2004 – 1.79 |
“A journal’s
impact factor is a measure of the frequency with which the
average article in a journal has been cited in a given
period of time,”
Dr. Marshall said.
Journal Impact Factor is from Journal Citation
Report (JCR), a product of Thomson ISI (Institute for
Scientific Information). JCR provides quantitative tools for
evaluating journals, and the impact factor is one of these.
“The impact factor is not the ‘be all to end all’ for the
Annals, but is one measure of our value to the medical
literature. Yet it still has to be considered when we
attempt to attract the very best manuscripts possible for
our readership. We have new and ongoing features that should
allow us to continue to improve our impact factor in the
future without compromising our responsibility to our
readership,” he said.
Deadline for abstract online submission is July 15
The deadline to electronically submit an abstract for the
2007 ACAAI Annual Meeting in Dallas is 11:59 p.m., Sunday,
July 15. Only electronic submissions will be accepted.
To submit an abstract, go to the ACAAI Web site and click on the headline "2007
Annual Meeting Abstract Submission." On-screen prompts will
take you through the submission process.
If you have already begun to enter an abstract in the system
-- but did not actually hit the "submit" button -- you must go back into the system and
submit. After the abstract is submitted, you will receive an
e-mail confirmation. Abstracts not officially submitted
cannot be considered.
View the new Literature Review Course vodcasts
Presentations from the popular Literature Review Course,
Everything You Should Have Read Last Year, But Didn’t, from
the 2006 ACAAI Annual Meeting, are vodcast weekly.
The new vodcasts include:
• Occupational and Environmental Allergy – Dr. Mark S.
Dykewicz (July 4-10)
• Asthma and Lower Respiratory Diseases – Dr. James T. Li
(July 11-17)
Previous vodcasts from the Literature Review Course, the
International Food Allergy Symposium and the “Asthma
Control: How Are We Doing?” symposium are archived for
continued viewing.
Each vodcast contains the original audio and presentation
slides, and can be viewed from a computer or downloaded to a
portable media player (such as an iPod). The ACAAI vodcast
program is sponsored through an unrestricted educational
grant from GlaxoSmithKline.
Dr. Ed O’Connell honored by Council of Science Editors
Dr.
Edward J. O’Connell, past ACAAI president (1990-91) and
former editor-in-chief of Annals of Allergy, Asthma &
Immunology (1998-2005), in Rochester, Minn., received the
CSE Distinguished Service Award from the Council of Science
Editors.
The purpose of the award is to “honor those individuals who
have worked diligently to further scientific communication
and have made significant contributions to the Council of
Science Editors.”
Dr. O’Connell has been on the CSE faculty for the past six
years teaching the “Short Course for Journal Editors” and
represented Annals at CSE meetings. |
|
|
Fellows-in-Training |
| |
Board Review Corner
Welcome to the Board Review Corner prepared by Soo Kim-Delio,
M.D., Senior Representative of ACAAI’s fellows-in-training (FITs)
to the Board of Regents. The Board Review Corner is your chance
to test your Board preparedness.
To refer to a previous Board Review Corner, click the “FIT
Archive” link in the left column.
Review Questions: Chapter 4 of Pediatric Allergy:
Principles & Practices, edited by Donald Y.M. Leung, et al.
Review questions were written by Drs. Bret Haymore and Soo Kim-Delio,
Walter Reed Army Medical Center.
 |
|